$AU 5 / share would value Cavatak at approximately $US 800 Million. We are a long way from that at the moment.
In any case, there's a lot going on in this space and it looks like BMS and Merck are front runners. I am hoping VLA gets some good results out soon and this share starts hitting the heights we all think it can.